{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:48:06Z","timestamp":1781002086440,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT","award":["NRF-2017R1A2B2011520"],"award-info":[{"award-number":["NRF-2017R1A2B2011520"]}]},{"name":"a Faculty Research Grant of Yonsei University College of Medicine for 2015","award":["6-2015-0055"],"award-info":[{"award-number":["6-2015-0055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1245\/s10434-018-6628-x","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T04:18:31Z","timestamp":1531973911000},"page":"3185-3192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacologic Properties of the Carrier Solutions for Hyperthermic Intraperitoneal Chemotherapy: Comparative Analyses Between Water and Lipid Carrier Solutions in the Rat Model"],"prefix":"10.1245","volume":"25","author":[{"given":"Eun Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyuk","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Joo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"issue":"1","key":"6628_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1525-1438.2007.00809.x","volume":"17","author":"K Fujiwara","year":"2007","unstructured":"Fujiwara K, Armstrong D, Morgan M, Markman M. Principles and practice of intraperitoneal chemotherapy for ovarian cancer. Int J Gynecol Cancer. 2007;17(1):1\u201320.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"6628_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","volume":"7","author":"WP Ceelen","year":"2010","unstructured":"Ceelen WP, Flessner MF. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol. 2010;7(2):108\u201315.","journal-title":"Nat Rev Clin Oncol"},{"key":"6628_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/720858","author":"L Smet De","year":"2013","unstructured":"De Smet L, Ceelen W, Remon JP, Vervaet C. Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent. Scientific World J. 2013. \n                    https:\/\/doi.org\/10.1155\/2013\/720858\n                    \n                  .","journal-title":"Scientific World J"},{"issue":"2","key":"6628_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4251\/wjgo.v2.i2.109","volume":"2","author":"TD Yan","year":"2010","unstructured":"Yan TD, Cao CQ, Munkholm-Larsen S. A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy. World J Gastrointest Oncol. 2010;2(2):109\u201316.","journal-title":"World J Gastrointest Oncol."},{"issue":"1","key":"6628_CR5","first-page":"29","volume":"7","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH, Van der Speeten K. Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol. 2016;7(1):29\u201344.","journal-title":"J Gastrointest Oncol."},{"issue":"5","key":"6628_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00280-003-0680-2","volume":"52","author":"F Mohamed","year":"2003","unstructured":"Mohamed F, Marchettini P, Stuart OA, Sugarbaker PH. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Cancer Chemother Pharmacol. 2003;52(5):405\u201310.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"6628_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1055-3207(03)00039-5","volume":"12","author":"F Mohamed","year":"2003","unstructured":"Mohamed F, Sugarbaker PH. Carrier solutions for intraperitoneal chemotherapy. Surg Oncol Clin N Am. 2003;12(3):813\u201324.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"6628_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/jso.21051","volume":"98","author":"S Kusamura","year":"2008","unstructured":"Kusamura S, Dominique E, Baratti D, Younan R, Deraco M. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2008;98(4):247\u201352.","journal-title":"J Surg Oncol"},{"issue":"3","key":"6628_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/PPO.0b013e3181a58d95","volume":"15","author":"K Speeten Van der","year":"2009","unstructured":"Van der Speeten K, Stuart OA, Sugarbaker PH. Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy. Cancer J. 2009;15(3):216\u201324.","journal-title":"Cancer J"},{"issue":"6","key":"6628_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ejso.2006.03.004","volume":"32","author":"D Elias","year":"2006","unstructured":"Elias D, Raynard B, Bonnay M, Pocard M. Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: pharmacologic studies. Eur J Surg Oncol. 2006;32(6):607\u201313.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"6628_CR11","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/annonc\/mdh398","volume":"15","author":"D Elias","year":"2004","unstructured":"Elias D, Matsuhisa T, Sideris L, et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol. 2004;15(10):1558\u201365.","journal-title":"Ann Oncol"},{"issue":"1","key":"6628_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpharm.2014.12.025","volume":"479","author":"AM Mehta","year":"2015","unstructured":"Mehta AM, Van den Hoven JM, Rosing H, et al. Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy. Int J Pharm. 2015;479(1):23\u20137.","journal-title":"Int J Pharm"},{"issue":"5","key":"6628_CR13","first-page":"303","volume":"5","author":"D Bois Du","year":"1989","unstructured":"Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303\u201311; discussion 312-3.","journal-title":"Nutrition."},{"key":"6628_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-1-4613-1247-5_26","volume":"82","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH, Averbach AM, Jacquet P, Stephens AD, Stuart OA. A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self-retaining retractor. Cancer Treat Res. 1996;82:415\u201321.","journal-title":"Cancer Treat Res"},{"issue":"20","key":"6628_CR15","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343.","journal-title":"J Clin Oncol"},{"issue":"5","key":"6628_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27(5):681\u20135.","journal-title":"J Clin Oncol"},{"issue":"7","key":"6628_CR17","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1245\/s10434-016-5143-1","volume":"23","author":"T Charrier","year":"2016","unstructured":"Charrier T, Passot G, Peron J, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with oxaliplatin increases the risk of postoperative hemorrhagic complications: analysis of predictive factors. Ann Surg Oncol. 2016;23(7):2315\u201322.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"6628_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1245\/s10434-007-9648-5","volume":"15","author":"WP Ceelen","year":"2008","unstructured":"Ceelen WP, Peeters M, Houtmeyers P, Breusegem C, De Somer F, Pattyn P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Ann Surg Oncol. 2008;15(2):535\u201341.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"6628_CR19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1023\/A:1008213732429","volume":"9","author":"E Raymond","year":"1998","unstructured":"Raymond E, Chaney S, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol. 1998;9(10):1053\u201371.","journal-title":"Ann Oncol"},{"issue":"2","key":"6628_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/annonc\/mdf019","volume":"13","author":"D Elias","year":"2002","unstructured":"Elias D, Bonnay M, Puizillou JM, et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002;13(2):267\u201372.","journal-title":"Ann Oncol"},{"issue":"4","key":"6628_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1245\/s10434-016-5665-6","volume":"24","author":"AM Mehta","year":"2017","unstructured":"Mehta AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, van den Heuvel SF, Verwaal VJ. Standard clinical protocol for bidirectional hyperthermic intraperitoneal chemotherapy (HIPEC): systemic leucovorin, 5-fluorouracil, and heated intraperitoneal oxaliplatin in a chloride-containing carrier solution. Ann Surg Oncol. 2017;24(4):990\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6628_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36\u201348.","journal-title":"Adv Drug Deliv Rev"},{"key":"6628_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.addr.2016.07.001","volume":"108","author":"GR Dakwar","year":"2017","unstructured":"Dakwar GR, Shariati M, Willaert W, Ceelen W, De Smedt SC, Remaut K. Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis\u2014mission possible? Adv Drug Deliv Rev. 2017;108:13\u201324.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"6628_CR24","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1002\/jps.21732","volume":"98","author":"E Jerremalm","year":"2009","unstructured":"Jerremalm E, Wallin I, Ehrsson H. New insights into the biotransformation and pharmacokinetics of oxaliplatin. J Pharm Sci. 2009;98(11):3879\u201385.","journal-title":"J Pharm Sci"},{"issue":"4","key":"6628_CR25","first-page":"1205","volume":"6","author":"MA Graham","year":"2000","unstructured":"Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E. Clinical pharmacokinetics of oxaliplatin: a critical review. Clin Cancer Res. 2000;6(4):1205\u201318.","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6628-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6628-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6628-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T23:03:24Z","timestamp":1563404604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6628-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["6628"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6628-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,18]]},"assertion":[{"value":"30 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest or financial ties of disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}